The Efficacy of Current Prognostic Models in Predicting Outcome of Patients with Myelodysplastic Syndromes (MDS) at the Time of Hypomethylating Agent Failure

被引:0
|
作者
Nazha, Aziz [1 ]
Komrokji, Rami S. [2 ]
Garcia-Manero, Guillermo [3 ]
Barnard, John [1 ]
Zimmerman, Cassie [1 ]
Najla, Al Ali [4 ]
Roboz, Gail J. [5 ]
Steensma, David P. [6 ]
DeZern, Amy E. [7 ]
Jabbour, Elias [3 ]
Lee, Sangmin [8 ]
Greenberg, Molly D. [9 ]
List, Alan F. [4 ]
Kantarjian, Hagop M. [3 ]
Maciejewski, Jaroslaw P. [1 ]
Sekeres, Mikkael A. [1 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA
[6] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Johns Hopkins Univ, Baltimore, MD USA
[8] Weill Cornell New York Presbyterian Hosp, New York, NY USA
[9] Weill Cornell Med Coll, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] A Novel Prognostic Model in Heavily Treated Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Seastone, David J.
    Radivoyevitch, Tomas
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Carraway, Hetty E.
    Advani, Anjali S.
    Kalaycio, Matt E.
    Rupp, Gina
    Colaluka, Kristin
    Hobson, Sean
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2014, 124 (21)
  • [42] Genomic Evolution of Patients with Myelodysplastic Syndrome after Hypomethylating Agent Failure
    Chien, Kelly S.
    Kim, Kunhwa
    Li, Ziyi
    Kanagal-Shamanna, Rashmi
    Ong, Faustine
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Jabbour, Elias
    Pemmaraju, Naveen
    Hammond, Danielle
    Short, Nicholas
    Ravandi, Farhad
    Alvarado, Yesid
    Pierce, Sherry A.
    Dong, Xiao Qin
    Yang, Hui
    Wei, Yue
    Ganan-Gomez, Irene
    Colla, Simona
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2022, 140 : 9773 - 9775
  • [43] Predictive Factors for Response and Survival in Patients with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMA) Failure: Primary Resistance (PriRes) Vs. Secondary Resistance (SecRes)
    Sasaki, Koji
    Jabbour, Elias
    Pemmaraju, Naveen
    Daver, Naval G.
    Kadia, Tapan M.
    DiNardo, Courtney D.
    Pierce, Sherry
    Borthakur, Gautam
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2014, 124 (21)
  • [44] Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia
    Ball, Brian
    Komrokji, Rami S.
    Ades, Lionel
    Sekeres, Mikkael A.
    DeZern, Amy E.
    Pleyer, Lisa
    Vey, Norbert
    Almeida, Antonio
    Germing, Ulrich
    Cluzeau, Thomas
    Platzbecker, Uwe
    Gore, Steven D.
    Fenaux, Pierre
    Prebet, Thomas
    BLOOD ADVANCES, 2018, 2 (16) : 2063 - 2071
  • [45] Risk Stratification in Hypomethylating Agent-Treated Patients With Myelodysplastic Syndromes: A Multivariate Model
    Chien, Kelly S.
    Li, Ziyi
    Urrutia, Samuel
    Kanagal-Shamanna, Rashmi
    Abdelhakeem, Ahmed
    Abuasab, Tareq
    Almanza, Emmanuel
    Ricos, Georgina Gener
    Bataller, Alex
    Bazinet, Alexandre
    Montalban-Bravo, Guillermo
    Short, Nicholas
    Kadia, Tapan M.
    Ravandi, Farhad
    Borthakur, Gautam
    Hammond, Danielle E.
    Swaminathan, Mahesh
    Sasaki, Koji
    Dong, Xiao Qin
    Pierce, Sherry A.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S398 - S398
  • [46] A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy
    Yalniz, Fevzi F.
    Berdeja, Jesus G.
    Maris, Michael B.
    Lyons, Roger M.
    Reeves, James A., Jr.
    Essell, James H.
    Patel, Prapti
    Sekeres, Mikkael
    Hughes, Amanda
    Mappa, Silvia
    Garcia-Manero, Guillermo
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (03) : 404 - 412
  • [47] Performance of the Molecular International Prognostic Scoring System (IPSS-M) in Hypomethylating Agent-Treated Patients with Myelodysplastic Syndromes
    Chien, Kelly S.
    Urrutia, Samuel
    Li, Ziyi
    Kanagal-Shamanna, Rashmi
    Abdelhakeem, Ahmed
    Abuasab, Tareq
    Almanza, Emmanuel
    Gener-Ricos, Georgina
    Bataller, Alex
    Bazinet, Alexandre
    Montalban-Bravo, Guillermo
    Short, Nicholas J.
    Jabbour, Elias
    Kadia, Tapan M.
    Ravandi, Farhad
    Borthakur, Gautam
    Hammond, Danielle E.
    Swaminathan, Mahesh
    Sasaki, Koji
    Dong, Xiao Qin
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2023, 142
  • [48] Prognostic Factors for Post-Transplant Outcomes in Patients with Myelodysplastic Syndromes (MDS)
    Bejanyan, Nelli
    Maciejewski, Jaroslaw P.
    Rybicki, Lisa
    O'Keefe, Christine L.
    Nyatanga, Nolyn
    Tench, Shawnda
    Sekeres, Mikkael A.
    Advani, Anjali S.
    Saunthararajah, Yogen
    Duong, Hien
    Sobecks, Ronald
    Kalaycio, Matt
    Bolwell, Brian J.
    Copelan, Edward A.
    BLOOD, 2011, 118 (21) : 881 - 881
  • [49] ADDING MOLECULAR DATA TO PROGNOSTIC MODELS CAN IMPROVE THEIR PREDICTIVE POWER IN TREATED PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Nazha, A.
    Al-Issa, K.
    Zarzour, A.
    Radivoyevitch, T.
    Hamilton, B.
    Gerds, A.
    Mukherjee, S.
    Adema, V.
    Clemente, M.
    Patel, B.
    Hirsch, C.
    Advani, A.
    Bartlomiej, P.
    Carraway, H.
    Maciejewski, J.
    Sekeres, M.
    LEUKEMIA RESEARCH, 2017, 55 : S33 - S34
  • [50] A REGRESSION EQUATION FOR PREDICTING SURVIVAL IN MYELODYSPLASTIC SYNDROMES (MDS) - RESULTS OF A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN 370 PATIENTS
    SANZ, GF
    VALLESPI, T
    CANIZO, MC
    SANZ, MA
    TORRABADELLA, M
    SANMIGUEL, J
    GARCIA, S
    IRRIGUIBLE, D
    BLUT, 1988, 56 (06): : C14 - C14